Administrative Supplements for P30 Cancer Centers Support Grants (CCSG) to Stimulate Research in HIV/AIDS Cancer Research Projects at NCI-designated Cancer Centers

February 13, 2018

DF/HCC has received from NCI two separate P30 supplement opportunities in AIDS-related malignancies and Non-AIDS Defining Cancers(NADCs). DF/HCC is allowed to submit only one application per supplement opportunity.

Internal DF/HCC Deadline: March 1, 2018
Award Amount: A Cancer Center may request funding for 1-2 years, up to $200K (Total Costs) per year
Award Availability: Notification by week of 3/5/18 for funds by September, 2018.

We will conduct an internal review at DF/HCC to select projects for each opportunity. Applications may include more than one pilot research project. If you have a project you would like considered for inclusion in one of these applications, please submit the following information by e-mail to Drew Memmott and Deborah Goff, no later than 3/1/18:

  1. Name, academic title, institutional affiliation
  2. Supplement Opportunity for which you would like to be considered (HIV/AIDS, or Non-AIDS)
  3. Title plus one-page description of project
  4. General details of the budget for your project (one or two years, Total Costs per year requested)
  5. NIH biosketch for key project personnel 

Investigators will be notified during the week of 3/5/18 if their project has been selected for the supplement application.

Related files